Jonathan E. Kolitz

24.2k citations
256 papers · 14.4k · 3 hit papers · h-index 61

Impact in

  • Genetics top 0.02%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematology top 0.05%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments

Papers in

    • Acute Myeloid Leukemia Research 128
    • Chronic Myeloid Leukemia Treatments 33
    • Chronic Lymphocytic Leukemia Research 80
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 19

Jonathan E. Kolitz

242 papers receiving 14.2k citations

Jonathan E. Kolitz's Hit Papers

IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study 2010 · 555 citations
5550+9+18Years since publication50010001.5k

Peers

Jonathan E. Kolitz
Comparison fields: 5 of 124
  • Genetics 6.3k
  • Hematology 6.3k
  • Pathology and Forensic Medicine 3.4k
  • Immunology 3.3k
  • Cancer Research 1.3k
Replace Alessandra Ferrajoli with:
Alessandra Ferrajoli United States
Jan A. Burger United States
Gunnar Juliusson Sweden
Emili Montserrat Spain
Steven P. Treon United States
Konstanze Döhner Germany
Paolo Ghia Italy
Stephan Stilgenbauer Germany
Ian W. Flinn United States
Ramón García‐Sánz Spain
Jonathan E. Kolitz relative to Alessandra Ferrajoli United States Alessandra Ferrajoli's profile →
Citations per field
00.5×1.7×
Alessandra Ferrajoli · 1×
Citations per year

Countries citing papers authored by Jonathan E. Kolitz

Since Specialization
Citations

This map shows the geographic impact of Jonathan E. Kolitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Kolitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Kolitz more than expected).

Fields of papers citing papers by Jonathan E. Kolitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan E. Kolitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Kolitz. The network helps show where Jonathan E. Kolitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan E. Kolitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan E. Kolitz Line = papers co-authored together Jonathan E. Kolitz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 256 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
Hit paper breakdown →
19991901
2
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
Hit paper breakdown →
2000753
3
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Hit paper breakdown →
2010555
4 2006464
5 2005435
6 2008315
7 2004314
8 1991290
9 2002271
10 2005267
11 2014265
12 2009244
13 2011241
14 1991228
15 2008224
16 2000195
17 2007188
18
Pharmacokinetics of recombinant interleukin 2 in humans.
1990176
19 2003175
20 2004175

About Jonathan E. Kolitz

Jonathan E. Kolitz is a scholar working on Hematology, Genetics, Molecular Biology, Immunology and Public Health, Environmental and Occupational Health, having authored 256 papers that have together received 14.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (128 papers), Chronic Lymphocytic Leukemia Research (80 papers), Acute Lymphoblastic Leukemia research (48 papers), Lymphoma Diagnosis and Treatment (39 papers), Immunodeficiency and Autoimmune Disorders (36 papers), Chronic Myeloid Leukemia Treatments (33 papers), Monoclonal and Polyclonal Antibodies Research (22 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers). The work is most often cited by research in Genetics (6.3k citations), Hematology (6.3k citations), Pathology and Forensic Medicine (3.4k citations), Immunology (3.3k citations) and Cancer Research (1.3k citations). Jonathan E. Kolitz has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Richard A. Larson, Steven L. Allen, Clara D. Bloomfield, Nicholas Chiorazzi, Bayard L. Powell, Krzysztof Mrózek, Guido Marcucci, Andrew J. Carroll, Rajendra N. Damle and Manlio Ferrarini. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Blood Advances and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact